Erythromycin
Introduction:
Erythromycin, produced by streptomycin, is an alkaline antibiotic. These include erythromycin A (ERA), erythromycin B (ERB), erythromycin C (ERC), erythromycin D (ERD), erythromycin e (ERE) and erythromycin f (ERF). Its free base is for oral use and lactose acid salt can be used for injection. It belongs to macrolide narrow-spectrum antibiotics. It is commonly used for Gram-positive bacteria resistant to penicillin and substitutes allergic to penicillin. The antibacterial spectrum is similar to penicillin.
Physical and chemical properties:
White or off white crystalline powder; Odorless and bitter; Slightly hygroscopic; Weakly alkaline, slightly soluble in water (about 0.2%), easily soluble in organic solvents. Unstable under acidic conditions.
CAS:114-07-8
Molecular formula: C37H67NO13
Molecular weight: 733.93
Structural type:
Purpose:
Erythromycin can treat digestive system diseases, and em can promote the whole gastrointestinal tract to varying degrees. It mainly has the following effects: promoting esophageal contraction and increasing lower esophageal sphincter pressure (LESP); Promote the contraction of gastric antrum and improve the coordination of gastric antrum and duodenum function; Induce gastrointestinal transit complex movement; Promote colon movement and gallbladder contraction. Therefore, it can effectively treat gastrointestinal diseases.
Erythromycin, produced by streptomycin, is an alkaline antibiotic. They include erythromycin A (ERA), erythromycin B (ERB), erythromycin C (ERC), erythromycin D (ERD), erythromycin e (ERE) and erythromycin f (ERF). It is a macrolide antibiotic with narrow spectrum. It is commonly used as a substitute for penicillin resistant Gram-positive bacteria infection and allergy to penicillin. Its antibacterial spectrum is similar to that of penicillin. Clinically, it is commonly used in patients with penicillin resistant gram-negative bacteria infection and penicillin allergy. It can be used as the first choice for Legionella pneumonia, mycoplasma pneumonia, infant pneumonia caused by Chlamydia trachomatis and colitis, skin and soft tissue infection. It can also be used for respiratory tract infection caused by hemolytic streptococcus and pneumococcus. It is also suitable for patients with diphtheria, The efficacy of this product combined with diphtheria antitoxin is enhanced.
IUPAC
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione
SMILES
CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)O)C)C)O)(C)O